User:David Canner/Sandbox 2: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
**Alzheimer’s Disease | |||
[[Acetylcholinesterase]] | ***[[Acetylcholinesterase]] | ||
[[Amyloid Beta]] | ***[[Amyloid Beta]] | ||
[[Gamma-Secratase]] | ***[[Gamma-Secratase]] | ||
[[Glutamate receptor (GluA2)]] | ***[[Glutamate receptor (GluA2)]] | ||
**Anemia | |||
[[Erythropoietin]] | ***[[Erythropoietin]] | ||
**Asthma and other Pulmonary Disease States | |||
[[Beta-2-Andrenergic Receptor]] | ***[[Beta-2-Andrenergic Receptor]] | ||
[[Leukotriene Receptor]] | ***[[Leukotriene Receptor]] | ||
**Autoimmune Diseases | |||
[[Tumor Necrosis Factor Receptor]] | ***[[Tumor Necrosis Factor Receptor]] | ||
**Blood Clots & Thrombic Events | |||
[[P2Y12]] | ***[[P2Y12]] | ||
**Cancer | **Cancer | ||
***Growth Factors | ***Growth Factors | ||
****Epidermal Growth Factor | ****Epidermal Growth Factor | ||
| Line 43: | Line 43: | ||
****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
****[[Tyrosine Kinase]] | ****[[Tyrosine Kinase]] | ||
**[[Heat Shock Protein 90]] | ***[[Heat Shock Protein 90]] | ||
**[[p53]] | ***[[p53]] | ||
**[[Mammalian Target of Rapamycin]] | ***[[Mammalian Target of Rapamycin]] | ||
**Compromised Immune System | |||
[[Granulocyte-macrophage colony-stimulating factor]] | ***[[Granulocyte-macrophage colony-stimulating factor]] | ||
**Diabetes & Hypoglycemia | |||
[[Peroxisome Proliferator-Activated Receptors]] | ***[[Peroxisome Proliferator-Activated Receptors]] | ||
**Digestive Diseases | |||
[[Proton Pump]] | ***[[Proton Pump]] | ||
**Erectile Dysfunction | |||
[[cGMP-Specific Phosphodiesterase Type 5]] | ***[[cGMP-Specific Phosphodiesterase Type 5]] | ||
**HIV | |||
[[Reverse Transcriptase]] | ***[[Reverse Transcriptase]] | ||
**Hypercholesterolemia (Elevated Cholesterol) | |||
[[HMG-CoA Reductase]] | ***[[HMG-CoA Reductase]] | ||
**Hypertension & Congestive Heart Failure | |||
[[Angiotensin-Converting Enzyme]] | ***[[Angiotensin-Converting Enzyme]] | ||
[[Calcium Channel]] | ***[[Calcium Channel]] | ||
**Inflammation & Rheumatoid Arthritis | |||
[[Cyclooxygenase]] | ***[[Cyclooxygenase]] | ||
**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | |||
[[Dopamine Receptor]] | ***[[Dopamine Receptor]] | ||
[[Andrenergic Receptor]] | ***[[Andrenergic Receptor]] | ||
[[Histamine Receptor]] | ***[[Histamine Receptor]] | ||
[[Opioid Receptor]] | ***[[Opioid Receptor]] | ||
}} | }} | ||
Latest revision as of 09:02, 17 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
